Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Multiple Dose Study of LY3502970 in Healthy Participants
Sponsor: Eli Lilly and Company
Summary
The main purpose of this study is to assess how fast LY3502970 gets into the blood stream and how long it takes the body to remove it when administered in multiple oral doses as new formulation compared to that of reference LY3502970 formulation. Information about safety and tolerability will be collected. The study is open to healthy participants. The study is conducted in two parts and it will last up to about 6 months, inclusive of screening period.
Official title: A Multiple Dose Study in Healthy Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2021-09-16
Completion Date
2022-04-04
Last Updated
2026-05-29
Healthy Volunteers
Yes
Conditions
Interventions
LY3502970
Administered orally.
Esomeprazole
Administered orally.
Locations (1)
Quotient Clinical Ltd
Nottingham, United Kingdom